Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway

Cell Death and Disease

Volumn 6, Issue 5, 2015, Pages

  Saurus, P ^a   Kuusela, S ^a   Lehtonen, E ^a   Hyvonen M E ^a   Ristola, M ^a   Fogarty, C L ^a,b,c   Tienari, J ^c   Lassenius, M I ^a,b,c   Forsblom, C ^a,b,c   Lehto, M ^a,b,c   Saleem, M A ^d   Groop, P H ^a,b,c,e   Holthofer H ^a   Lehtonen, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GIT 27; GLUCOSE; IMMUNOMODULATING AGENT; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PODOCIN; PROTEIN KINASE B; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG; 3-PHENYL-4,5-DIHYDRO-5-ISOXAZOLE ACETIC ACID; ACETIC ACID DERIVATIVE; OXAZOLE DERIVATIVE; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; TOLL LIKE RECEPTOR;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; ELECTRON MICROSCOPY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; GLOMERULUS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INSULIN DEPENDENT DIABETES MELLITUS; LENTIVIRUS INFECTION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BLOOD; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ACETATES; ANIMALS; APOPTOSIS; DIABETES MELLITUS, TYPE 1; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; OXAZOLES; PODOCYTES; PROTEIN-SERINE-THREONINE KINASES; RATS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84940860220     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.125     Document Type: Article

References (57)

1. Nymark M, Pussinen PJ, Tuomainen AM, Forsblom C, Groop PH, Lehto M et al. Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care 2009; 32: 1689-1693.
2. Simonsen JR, Harjutsalo V, Jarvinen A, Kirveskari J, Forsblom C, Groop PH et al. Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study. BMJ Open Diabetes Res Care 2015; 3: e000067.
3. Pussinen PJ, Paju S, Mantyla P, Sorsa T. Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem 2007; 14: 2402-2412.
4. Laugerette F, Vors C, Geloen A, Chauvin MA, Soulage C, Lambert-Porcheron S et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 2011; 22: 53-59.
5. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86: 1286-1292.
6. Cantaluppi V, Assenzio B, Pasero D, Camussi G, Ranieri VM. Polymyxin-B hemo perfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008; 34: 1638-1645.
7. Steffes MW, Schmidt D, McCrery R, Basgen JMInternational Diabetic Nephropathy Study Group, Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001; 59: 2104-2113.
8. Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 2007; 72: 1262-1272.
9. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 1999; 42: 1341-1344.
10. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000; 15: 1379-1383.
11. Keledjian KM, Marasa BS, Wang JY, Rao JN. Induced PDK1 kinase activity suppresses apoptosis in intestinal epithelial cells by activating Akt signaling following polyamine depletion. Int J Clin Exp Med 2012; 5: 221-228.
12. Hashimoto N, Kido Y, Uchida T, Asahara S, Shigeyama Y, Matsuda T et al. Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet 2006; 38: 589-593.
13. Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tait V, Malone L et al. Essential role of PDK1 in regulating cell size and development in mice. EMBO J 2002; 21: 3728-3738.
14. Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N, Norman DG et al. 3- Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 1997; 7: 776-789.
15. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000; 346(Pt 3): 561-576.
16. Burn TC, Connors TD, Van Raay TJ, Dackowski WR, Millholland JM, Klinger KW et al. Generation of a transcriptional map for a 700-kb region surrounding the polycystic kidney disease type 1 (PKD1) and tuberous sclerosis type 2 (TSC2) disease genes on human chromosome 16p3.3. Genome Res 1996; 6: 525-537.
17. Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225-233.
18. Liu BC, Song X, Lu XY, Li DT, Eaton DC, Shen BZ et al. High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. Biochim Biophys Acta 2013; 1833: 1434-1442.
19. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-348.
20. Chua Jr SC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994-996.
21. Kim J, Sohn E, Kim CS, Kim JS. Renal podocyte apoptosis in Zucker diabetic fatty rats: involvement of methylglyoxal-induced oxidative DNA damage. J Comp Pathol 2011; 144: 41-47.
22. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167-182.
23. Srivastava T, Sharma M, Yew KH, Sharma R, Duncan RS, Saleem MA et al. LPS and PANinduced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile. J Cell Commun Signal 2013; 7: 49-60.
24. Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E et al. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008; 19: 704-713.
25. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
26. Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 2008; 74: 22-36.
27. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
28. Cunningham PN, Holers VM, Alexander JJ, Guthridge JM, Carroll MC, Quigg RJ. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. Kidney Int 2000; 58: 1580-1587.
29. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397.
30. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-442.
31. Bannerman DD, Goldblum SE. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003; 284: L899-L914.
32. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186: 1831-1841.
33. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168: 5817-5823.
34. Guo R,Wang Y, Minto AW, Quigg RJ, Cunningham PN. Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 2004; 15: 3093-3102.
35. Sun Y, He L, Takemoto M, Pikkarainen T, Genové G, Norlin J et al. Glomerular transcriptome changes associated with lipopolysaccharide-induced proteinuria. Am J Nephrol 2009; 29: 558-570.
36. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 2000; 157: 597-603.
37. Sun X, Fang Z, Zhu Z, Yang X, He F, Zhang C. Effect of down-regulation of TRPC6 on the puromycin aminonucleoside-induced apoptosis of mouse podocytes. J Huazhong Univ Sci Technolog Med Sci 2009; 29: 417-422.
38. Lee SC, Han SH, Li JJ, Lee SH, Jung DS, Kwak SJ et al. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int 2009; 76: 838-848.
39. Kikani CK, Verona EV, Ryu J, Shen Y, Ye Q, Zheng L et al. Proliferative and antiapoptotic signaling stimulated by nuclear-localized PDK1 results in oncogenesis. Sci Signal 2012; 5: ra80.
40. Sawamukai N, Saito K, Yamaoka K, Nakayamada S, Ra C, Tanaka Y. Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells. J Immunol 2007; 179: 6479-6484.
41. Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY et al. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 2002; 91: 406-415.
42. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P et al. Endotoxintolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-625.
43. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752.
44. Jialal I, Major AM, Devaraj S. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. J Diabetes Complications 2014; 28: 755-761.
45. Cha JJ, Hyun YY, Lee MH, Kim JE, Nam DH, Song HK et al. Renal protective effects of tolllike receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 2013; 154: 2144-2155.
46. Stojanovic I, Cuzzocrea S, Mangano K, Mazzon E, Miljkovic D, Wang M et al. In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. Clin Immunol 2007; 123: 311-323.
47. Dasu MR, Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab 2011; 300: E145-E154.
48. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008; 57: 3090-3098.
49. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008; 93: 578-583.
50. Stosic-Grujicic S, Cvetkovic I, Mangano K, Fresta M, Maksimovic-Ivanic D, Harhaji L et al. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice. J Pharmacol Exp Ther 2007; 320: 1038-1049.
51. Vaara M. Polymyxins and their novel derivatives. Curr Opin Microbiol 2010; 13: 574-581.
52. Min HS, Kim JE, Lee MH, Song HK, Lee MJ, Lee JE et al. Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet. Kidney Res Clin Pract 2014; 33: 33-44.
53. Orlando RA, Takeda T, Zak B, Schmieder S, Benoit VM, McQuistan T et al. The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol 2001; 12: 1589-1598.
54. Hyvonen ME, Saurus P, Wasik A, Heikkilä E, Havana M, Trokovic R et al. Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes. Mol Cell Endocrinol 2010; 328: 70-79.
55. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13: 630-638.
56. Wasik AA, Koskelainen S, Hyvonen ME, Musante L, Lehtonen E, Koskenniemi K et al. Ezrin is down-regulated in diabetic kidney glomeruli and regulates actin reorganization and glucose uptake via GLUT1 in cultured podocytes. Am J Pathol 2014; 184: 1727-1739.
57. van den Berg JG, van den Bergh Weerman MA, Assmann KJ, Weening JJ, Florquin S. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 2004; 66: 1901-1906.